SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001561743-21-000072
Filing Date
2021-08-30
Accepted
2021-08-30 09:05:33
Documents
15
Period of Report
2021-08-27
Items
Item 1.02: Termination of a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K kin-20210827.htm   iXBRL 8-K 58064
2 EX-3.1 exhibit31-amendedandrestat.htm EX-3.1 6330
3 EX-3.2 exhibit32-amendedandrestat.htm EX-3.2 117985
  Complete submission text file 0001561743-21-000072.txt   398885

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT kin-20210827.xsd EX-101.SCH 2300
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT kin-20210827_def.xml EX-101.DEF 17026
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT kin-20210827_lab.xml EX-101.LAB 31827
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT kin-20210827_pre.xml EX-101.PRE 17762
8 EXTRACTED XBRL INSTANCE DOCUMENT kin-20210827_htm.xml XML 14616
Mailing Address 1555 BAYSHORE HIGHWAY, SUITE 200 BURLINGAME CA 94010
Business Address 1555 BAYSHORE HIGHWAY, SUITE 200 BURLINGAME CA 94010 650-701-7901
Kindred Biosciences, Inc. (Filer) CIK: 0001561743 (see all company filings)

IRS No.: 461160142 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36225 | Film No.: 211221224
SIC: 2834 Pharmaceutical Preparations